| | | | | |
AGIO Agios Pharmaceuticals, Inc. | $28,7460 | +3,85% | $1,74B | $152,24K | |
SGRY Surgery Partners, Inc. Common Stock | $13,7350 | +1,67% | $1,74B | $468,34K | |
GAB The Gabelli Equity Trust Inc. | $5,6050 | -0,09% | $1,74B | $617,61K | |
HURN Huron Consulting Group Inc. | $106,73 | +1,84% | $1,74B | $33,77K | |
ENVX Enovix Corporation Common Stock | $8,2750 | +0,55% | $1,74B | $3,16M | |
PAYO Payoneer Global Inc. Common Stock | $5,1850 | +1,87% | $1,74B | $1,28M | |
ETV Eaton Vance Tax-Managed Buy-Write Opportunities Fund | $14,9350 | +0,17% | $1,73B | $109,48K | |
STGW Stagwell Inc. Class A Common Stock | $6,6850 | +1,44% | $1,73B | $355,14K | |
CASH Pathward Financial, Inc. Common Stock | $78,9350 | +1,54% | $1,73B | $67,96K | |
SNDX Syndax Pharmaceuticals, Inc. | $17,9050 | -2,37% | $1,73B | $4,73M | |
STRA Strategic Education, Inc. Common Stock | $80,9450 | +2,40% | $1,73B | $81,50K | |
CAPR Capricor Therapeutics Inc | $28,2130 | +2,07% | $1,73B | $225,50K | |
AAPG Ascentage Pharma Group International American Depository Shares | $18,4200 | +3,08% | $1,73B | $1,73K | |
SLS SELLAS Life Sciences Group, Inc. Common Stock | $8,8550 | +8,12% | $1,73B | $4,16M | |
PLSE Pulse Biosciences, Inc Common Stock (DE) | $27,4930 | +10,02% | $1,73B | $302,70K | |
